125 related articles for article (PubMed ID: 27951718)
21. Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome.
Pavelka Z; Zitterbart K; Nosková H; Bajčiová V; Slabý O; Štěrba J
Klin Onkol; 2019; 32(1):70-74. PubMed ID: 30764633
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
Uvirova M; Simova J; Kubova B; Dvorackova N; Tomaskova H; Sedivcova M; Dite P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):466-71. PubMed ID: 26077004
[TBL] [Abstract][Full Text] [Related]
24. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time?
Søreide K
Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726
[TBL] [Abstract][Full Text] [Related]
25. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
[TBL] [Abstract][Full Text] [Related]
26. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
27. No major difference in K-ras and p53 abnormalities in sporadic and hereditary nonpolyposis colorectal adenomas.
Voskuil DW; Kampman E; van Geloof W; Grubben M; Kok F; van Muijen G; Nagengast F; Vasen H; van't Veer P
Dig Dis Sci; 2000 Nov; 45(11):2187-94. PubMed ID: 11215737
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
[TBL] [Abstract][Full Text] [Related]
29. Clinically important molecular features of Peruvian colorectal tumours: high prevalence of DNA mismatch repair deficiency and low incidence of KRAS mutations.
Egoavil CM; Montenegro P; Soto JL; Casanova L; Sanchez-Lihon J; Castillejo MI; Martinez-Canto A; Perez-Carbonell L; Castillejo A; Guarinos C; Barbera VM; Jover R; Paya A; Alenda C
Pathology; 2011 Apr; 43(3):228-33. PubMed ID: 21436632
[TBL] [Abstract][Full Text] [Related]
30. Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities.
Silva P; Albuquerque C; Lage P; Fontes V; Fonseca R; Vitoriano I; Filipe B; Rodrigues P; Moita S; Ferreira S; Sousa R; Claro I; Nobre Leitão C; Chaves P; Dias Pereira A
Int J Mol Med; 2016 Sep; 38(3):687-702. PubMed ID: 27430658
[TBL] [Abstract][Full Text] [Related]
31. Genotoxicity of Cytolethal Distending Toxin (CDT) on Isogenic Human Colorectal Cell Lines: Potential Promoting Effects for Colorectal Carcinogenesis.
Graillot V; Dormoy I; Dupuy J; Shay JW; Huc L; Mirey G; Vignard J
Front Cell Infect Microbiol; 2016; 6():34. PubMed ID: 27047802
[TBL] [Abstract][Full Text] [Related]
32. Involvement of adenomatous polyposis coli in colorectal tumorigenesis.
Jaiswal AS; Balusu R; Narayan S
Front Biosci; 2005 May; 10():1118-34. PubMed ID: 15769611
[TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors.
Lin JK; Lin PC; Lin CH; Jiang JK; Yang SH; Liang WY; Chen WS; Chang SC
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S680-6. PubMed ID: 24841357
[TBL] [Abstract][Full Text] [Related]
34. Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies.
Jesinghaus M; Pfarr N; Kloor M; Endris V; Tavernar L; Muckenhuber A; von Knebel Doeberitz M; Penzel R; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2016 Mar; 55(3):268-77. PubMed ID: 26650777
[TBL] [Abstract][Full Text] [Related]
35. Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas.
Nagothu KK; Jaszewski R; Moragoda L; Rishi AK; Finkenauer R; Tobi M; Naumoff JA; Dhar R; Ehrinpreis M; Kucuk O; Majumdar AP
Cancer Detect Prev; 2003; 27(4):297-304. PubMed ID: 12893078
[TBL] [Abstract][Full Text] [Related]
36. [Mutational studies of adenomatous polyposis coli gene in carcinomas from patients with hereditary non-polyposis colorectal cancers].
Huang J; Jin SH; Zhang SZ; Zheng S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):196-9. PubMed ID: 12778442
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas.
Yoshioka Y; Togashi Y; Chikugo T; Kogita A; Taguri M; Terashima M; Mizukami T; Hayashi H; Sakai K; de Velasco MA; Tomida S; Fujita Y; Tokoro T; Ito A; Okuno K; Nishio K
Cancer; 2015 Dec; 121(24):4359-68. PubMed ID: 26488212
[TBL] [Abstract][Full Text] [Related]
38. Pathology of the hereditary colorectal carcinoma.
Gatalica Z; Torlakovic E
Fam Cancer; 2008; 7(1):15-26. PubMed ID: 17564815
[TBL] [Abstract][Full Text] [Related]
39. Early genetic aberrations in patients with sporadic colorectal cancer.
Druliner BR; Ruan X; Sicotte H; O'Brien D; Liu H; Kocher JA; Boardman L
Mol Carcinog; 2018 Jan; 57(1):114-124. PubMed ID: 28926134
[TBL] [Abstract][Full Text] [Related]
40. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN
Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]